Shanghai Jiahui International Hospital and Medtronic Announce Strategic Collaboration at CIIE 2022

ShanghaiNovember 7, 2022PR Newswire -- On the morning of November 7, 2022, Shanghai Jiahui International Hospital and Medtronic reached a strategic cooperation at the 5th China International Import Expo (CIIE) and were invited to participate in the "Breakthrough Growth, Innovation for Success" 2022 Medtronic Greater China Regional Growth Initiatives (RGI) Private Healthcare Development Forum. Mr. Feng Ge, CEO of Jiahui Medical, Dr. Naiqiang Xiang, Chief Medical Officer of Jiahui Medical and Medical Director of Shanghai Jiahui International Hospital, Ms. Shan Cao, Vice President of Corporate Affairs and Communications of Medtronic Greater China, and Mr. Xu Shao, National Business Director of Private Healthcare and Group Clients under Medtronic Greater China Regional Growth Initiatives, attended and delivered speeches.

Shanghai Jiahui International Hospital and Medtronic Reach Strategic Cooperation

As a pioneer in Shanghai's international medical service system, Jiahui has been selected as a designated hospital for medical security at the CIIE for five consecutive years, providing various medical guarantees for the event. It has successively won awards such as "Excellent Service, Strong Support" and "Most Beautiful Service Window." This year, in addition to continuing relevant upgrades, Jiahui will further provide specialized medical security, including formulating a special medical security work plan for the CIIE; establishing a "green channel" for CIIE personnel seeking medical treatment; reserving general wards, isolation wards, and ICU beds specifically for CIIE attendees while setting up dedicated emergency and operating rooms for security purposes; forming an in-hospital CIIE medical team; creating an emergency response team to handle various unexpected incidents requiring medical assistance; and offering daily medical services to foreign patients attending the CIIE.

Shanghai Jiahui International Hospital Selected as a Designated Hospital for CIIE for Five Consecutive Years

While providing medical support for various major events, Jiahui also closely collaborates with several top-tier medical enterprises and institutions both in China and abroad, such as Fosun Kite and the Shanghai Phage and Antibiotic Resistance Research Institute, to promote cooperation and exchange in academic discussions, discipline development, and clinical research, continuously practicing the brand value of "leading the future." In scientific research and education, Shanghai Jiahui International Hospital, in collaboration with J-Med (Jiahui Medical Research and Education), Shanghai Zhongshan Hospital, and the European Society of Surgical Oncology, jointly published the new journal *Clinical Surgical Oncology*. By publishing high-quality articles from experts and scholars in the field of oncology, it further advances the development of surgical oncology research, clinical practice, multidisciplinary management, and continuing education.

The collaboration with Medtronic marks another significant partnership for Jiahui in the "industry-academia-research" domain. Both parties will actively explore ways to enhance patient services, upgrade the supply chain, and implement clinical innovation solutions. Through this powerful alliance, they aim to promote the implementation and application of innovative services and multi-product solutions, providing patients with more cutting-edge and advanced therapies. "The name 'Jiahui' originates from the ancient Chinese text *Zhouyi*: 'Abundance is the gathering of excellence,' symbolizing the convergence of outstanding talents. We hope that Jiahui not only brings together top doctors and experts in the field but also integrates leading products and technologies to offer advanced healthcare solutions to more families, delivering lifelong medical care and service while positively promoting healthy living," shared Mr. Ge Feng, CEO of Jiahui Healthcare.

Mr. Shao Xu, National Business Director of Social Healthcare and Group Clients for Medtronic Greater China Regional Growth Initiatives, expressed equal excitement about this collaboration: "The signing with Jiahui represents Medtronic's steadfast continuation of its strategy to deeply cultivate the local market in China. We look forward to promoting the widespread application of new therapies and products through this strong partnership, enhancing technical capabilities, and improving diagnostic and treatment standards."

At the subsequent forum on the development of privately-run healthcare, Mr. Ge Feng shared his insights on the topic "How can international healthcare brands leverage their strengths to achieve differentiated brand development?" and discussed with other guests the future innovative development path for healthcare brands. "As an international healthcare brand, Jiahui is committed to providing evidence-based and patient-centered medical services that meet international standards. In the future, we will continue to focus on improving the quality of clinical care, enhance the convenience of medical consultations through multidisciplinary joint diagnosis and more comprehensive online medical services, help patients with long-term health management, and collaborate with multiple parties to jointly establish an integrated healthcare ecosystem that aligns with international standards."

As an innovative and integrated healthcare ecosystem in China, Shanghai Jiahui International Hospital will collaborate with Medtronic and other industry-leading institutions to jointly develop innovative medical technologies, deepen international treatment models, and provide patients and their families with one-stop comprehensive health management services.